@article{a4125aabdac34febbabdb592064fc1c3,
title = "Local Therapies in Advanced Colorectal Cancer",
keywords = "Ablative therapy, Colorectal cancer, Local therapy, Metastatic, Stereotactic ablative radiotherapy, Surgery",
author = "Hitchcock, \{Kathryn E.\} and Romesser, \{Paul B.\} and Miller, \{Eric D.\}",
note = "Funding Information: K.E. Hitchcock reports research relationships with Elekta, Merck, and BioMimetix that are unrelated to the topic of this review. P.B. Romesser is an EMD Serono consultant and reports support for travel from Elekta and Philips Healthcare and prior research funding from EMD Serono . P.B. Romesser is supported by an NIH/ NCI Cancer Center Support Grant ( P30 CA008748 ) and an NIH/NCI early career development award ( K08 CA255574 ). E.D. Miller has served as a consultant for Varian Medical Systems. This article was supported in part by the NIH ( grant P30 CA16058 ). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.",
year = "2022",
month = jun,
doi = "10.1016/j.hoc.2022.02.007",
language = "English",
volume = "36",
pages = "553--567",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
number = "3",
}